To further explore the impact of TINCR inactivation in human cancer we performed immunohistochemical analysis across two independent cohorts of cutaneous squamous cell carcinoma (cSCC) samples encompassing a total of 141 patient samples (HUCA n = 100; cSCC SK801c n = 41). The gene discussed is TINCR; the disease is cancer.